AI-Powered ASX Trading Signals

Real-time insights. Smarter decisions. Better trades.

🔍 Search Stocks 14 day Free Trial

4DMEDICAL LIMITED (4DX)


AI Coverage Rating: Low

ASX AI Signals has generated 0 signals for 4DX during the last 90 days, indicating low trading activity

4DX Share Price

Current Price$4.250
52 Week High$6.800
52 Week Low:$0.230
Trading at (% of 52 Week High) 62.50%


Volume 4405647
20 Day Avg 6561916
Relative Volume 67.1%


Business Overview

4DMedical Limited (ASX: 4DX) is a medical technology company that develops and commercializes imaging solutions to help diagnose lung diseases. Its flagship product, the XV Technology, provides advanced 4D lung imaging to improve respiratory health assessments. The company focuses on delivering innovative tools for healthcare professionals to enhance patient care.

ASX Sector Overview

Sector:   Health Care Equipment & Services

The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.

Latest AI Recommendation

Latest  4DMEDICAL LIMITED(4DX)   News

16 Jun 2026, 10:06 PM

bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans

Expert panel will share real-world case studies to demonstrate how mobile CT screening, noninvasive CyPath® Lung testing, and comprehensive functional lung imaging can reduce cost while improving access, early detection and outcomes for veterans National Association of Veterans' Research and Educat

25 Apr 2026, 12:06 PM

4DMedical GSK Lung Imaging Deal And What It May Mean For Investors

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. 4DMedical (ASX:4DX) has signed a contract with GlaxoSmithKline to supply quantitative lung imaging analytics. The agreement focuses on using 4DMedical’s technology in GSK’s drug development p

20 Apr 2026, 10:35 PM

AI & Technology Virtual Investor Conference Agenda Announced for April 23rd

Virtual Investor Conferences Company executives will discuss their business strategies, provide updates on recent developments, and answer questions live at VirtualInvestorConferences.com NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor co

12 Dec 2021, 08:04 AM

Is 4DMedical Limited's (ASX:4DX) Shareholder Ownership Skewed Towards Insiders?

The big shareholder groups in 4DMedical Limited (ASX:4DX) have power over the company. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. I quite like to see at least a little bit of insider ownership. As Charlie M

13 Sep 2021, 08:00 AM

We're Not Very Worried About 4DMedical's (ASX:4DX) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. Having said that, unprofitable companies are risky because they could po

Unlock All ASX AI Signals

Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.

14 Day Free Trial • Cancel Anytime • Founders Price $15/month

Start My Free Trial